KA
Karen Andreas
View Karen's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
Present
Company Details
2-10 Employees
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
2001 Market Street
Suite 3915, Unit 15
Philadelphia, Pennsylvania 19103, US
Keywords
Oncology and Bispecific Antibody
Contact Details
- Email AddressK**@contexttherapeutics.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
You May Also Interested In
- DLDetailsDeepak LalaSenior Partner And FounderWorked together at Context Therapeutics
- MADetailsMary Anne Mc CarthyWorked together at Context Therapeutics
- SADetailsScott ApplebaumChief Legal Officer & Chief Business Officer (From January 2023)Worked together at Context Therapeutics
Find verified contacts of Karen Andreas in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.